These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24247848)

  • 1. Effect of carbon monoxide donor CORM-2 on vitamin D3 metabolism.
    Feger M; Fajol A; Lebedeva A; Meissner A; Michael D; Voelkl J; Alesutan I; Schleicher E; Reichetzeder C; Hocher B; Qadri SM; Lang F
    Kidney Blood Press Res; 2013; 37(4-5):496-505. PubMed ID: 24247848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 25-Hydroxyvitamin D3 1-α-hydroxylase-dependent stimulation of renal klotho expression by spironolactone.
    Alesutan I; Feger M; Pakladok T; Mia S; Ahmed MS; Voelkl J; Lang F
    Kidney Blood Press Res; 2013; 37(4-5):475-87. PubMed ID: 24247665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of renal klotho expression by Shiga toxin 2.
    Feger M; Mia S; Pakladok T; Nicolay JP; Alesutan I; Schneider SW; Voelkl J; Lang F
    Kidney Blood Press Res; 2014; 39(5):441-9. PubMed ID: 25471359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous carbon monoxide suppresses Escherichia coli vitality and improves survival in an Escherichia coli-induced murine sepsis model.
    Shen WC; Wang X; Qin WT; Qiu XF; Sun BW
    Acta Pharmacol Sin; 2014 Dec; 35(12):1566-76. PubMed ID: 25399652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular mechanism of inhibition of early pulmonary injury and inflammatory response by exogenous carbon monoxide: experiment with mice].
    Sun BW; Chen X; Chen ZY; Katada K; Cepinskas G
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3148-51. PubMed ID: 18269877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon monoxide-sensitive apoptotic death of erythrocytes.
    Lang E; Qadri SM; Jilani K; Zelenak C; Lupescu A; Schleicher E; Lang F
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):348-55. PubMed ID: 22726235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon monoxide induces cyclooxygenase-2 expression through MAPKs and PKG in phagocytes.
    Lin LC; Ho FM; Yen SJ; Wu PY; Hung LF; Huang WJ; Liang YC
    Int Immunopharmacol; 2010 Dec; 10(12):1520-5. PubMed ID: 20840837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphate Homeostasis, Inflammation and the Regulation of FGF-23.
    Lang F; Leibrock C; Pandyra AA; Stournaras C; Wagner CA; Föller M
    Kidney Blood Press Res; 2018; 43(6):1742-1748. PubMed ID: 30504710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications.
    Winburn IC; Gunatunga K; McKernan RD; Walker RJ; Sammut IA; Harrison JC
    Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):31-41. PubMed ID: 22269084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context.
    Vadori M; Seveso M; Besenzon F; Bosio E; Tognato E; Fante F; Boldrin M; Gavasso S; Ravarotto L; Mann BE; Simioni P; Ancona E; Motterlini R; Cozzi E
    Xenotransplantation; 2009; 16(2):99-114. PubMed ID: 19392725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CO-releasing molecule CORM-3 protects against articular degradation in the K/BxN serum transfer arthritis model.
    Maicas N; Ferrándiz ML; Devesa I; Motterlini R; Koenders MI; van den Berg WB; Alcaraz MJ
    Eur J Pharmacol; 2010 May; 634(1-3):184-91. PubMed ID: 20184873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice.
    Cepinskas G; Katada K; Bihari A; Potter RF
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G184-91. PubMed ID: 17991708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon monoxide from CORM-2 reduces HMGB1 release through regulation of IFN-β/JAK2/STAT-1/INOS/NO signaling but not COX-2 in TLR-activated macrophages.
    Tsoyi K; Nizamutdinova IT; Jang HJ; Mun L; Kim HJ; Seo HG; Lee JH; Chang KC
    Shock; 2010 Dec; 34(6):608-14. PubMed ID: 20442692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved myocardial function after cold storage with preservation solution supplemented with a carbon monoxide-releasing molecule (CORM-3).
    Musameh MD; Green CJ; Mann BE; Fuller BJ; Motterlini R
    J Heart Lung Transplant; 2007 Nov; 26(11):1192-8. PubMed ID: 18022087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactive properties of iron-containing carbon monoxide-releasing molecules.
    Sawle P; Hammad J; Fairlamb IJ; Moulton B; O'Brien CT; Lynam JM; Duhme-Klair AK; Foresti R; Motterlini R
    J Pharmacol Exp Ther; 2006 Jul; 318(1):403-10. PubMed ID: 16603670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery.
    Varadi J; Lekli I; Juhasz B; Bacskay I; Szabo G; Gesztelyi R; Szendrei L; Varga E; Bak I; Foresti R; Motterlini R; Tosaki A
    Life Sci; 2007 Apr; 80(17):1619-26. PubMed ID: 17321552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
    Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
    J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
    Feger M; Ewendt F; Strotmann J; Schäffler H; Kempe-Teufel D; Glosse P; Stangl GI; Föller M
    J Mol Med (Berl); 2021 May; 99(5):699-711. PubMed ID: 33517471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.